Christopher C. Rider

2.7k total citations
63 papers, 2.3k citations indexed

About

Christopher C. Rider is a scholar working on Molecular Biology, Cell Biology and Cancer Research. According to data from OpenAlex, Christopher C. Rider has authored 63 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 14 papers in Cell Biology and 10 papers in Cancer Research. Recurrent topics in Christopher C. Rider's work include Glycosylation and Glycoproteins Research (14 papers), Proteoglycans and glycosaminoglycans research (13 papers) and S100 Proteins and Annexins (8 papers). Christopher C. Rider is often cited by papers focused on Glycosylation and Glycoproteins Research (14 papers), Proteoglycans and glycosaminoglycans research (13 papers) and S100 Proteins and Annexins (8 papers). Christopher C. Rider collaborates with scholars based in United Kingdom, United States and Canada. Christopher C. Rider's co-authors include C. Barr Taylor, Barbara Mulloy, Rosemary S. Mummery, Hilary A. Harrop, Deirdre R. Coombe, Lawrence Ramsden, Roslyn V. Gibbs, Myrtle Y. Gordon, Anthony D. Stead and Philip Beesley and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Biochemistry.

In The Last Decade

Christopher C. Rider

63 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher C. Rider United Kingdom 27 1.3k 568 285 215 199 63 2.3k
Amit Choudhury United States 25 1.6k 1.2× 1.1k 2.0× 232 0.8× 76 0.4× 232 1.2× 41 2.7k
José S. Ramalho Portugal 32 1.6k 1.2× 1.2k 2.0× 358 1.3× 132 0.6× 190 1.0× 82 2.8k
Takeshi Matsui Japan 26 1.7k 1.3× 1.1k 1.9× 299 1.0× 361 1.7× 461 2.3× 55 3.6k
Si‐Tse Jiang Taiwan 25 977 0.7× 267 0.5× 270 0.9× 199 0.9× 101 0.5× 55 1.8k
Christian Zuber Switzerland 29 1.7k 1.3× 844 1.5× 484 1.7× 80 0.4× 145 0.7× 65 2.5k
Robert Halenbeck United States 20 1.7k 1.3× 323 0.6× 1.1k 4.0× 173 0.8× 537 2.7× 23 3.0k
Masahiro Oka Japan 30 2.9k 2.2× 364 0.6× 237 0.8× 104 0.5× 315 1.6× 81 4.2k
Martin L. Biniossek Germany 29 1.3k 0.9× 372 0.7× 150 0.5× 123 0.6× 515 2.6× 83 2.3k
François Dautry France 30 2.2k 1.7× 218 0.4× 404 1.4× 89 0.4× 420 2.1× 61 3.1k
François Amalric France 42 3.6k 2.7× 498 0.9× 750 2.6× 102 0.5× 455 2.3× 76 4.7k

Countries citing papers authored by Christopher C. Rider

Since Specialization
Citations

This map shows the geographic impact of Christopher C. Rider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher C. Rider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher C. Rider more than expected).

Fields of papers citing papers by Christopher C. Rider

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher C. Rider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher C. Rider. The network helps show where Christopher C. Rider may publish in the future.

Co-authorship network of co-authors of Christopher C. Rider

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher C. Rider. A scholar is included among the top collaborators of Christopher C. Rider based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher C. Rider. Christopher C. Rider is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Neibergs, Holly L., et al.. (2024). Novel ryanodine receptor 1 (RYR1) missense gene variants in two pet dogs with fatal malignant hyperthermia identified by next-generation sequencing. Veterinary Anaesthesia and Analgesia. 52(1). 8–18. 1 indexed citations
2.
3.
Norman, Jill T., et al.. (2016). The binding of the bone morphogenetic protein antagonist gremlin to kidney heparan sulfate: Such binding is not essential for BMP antagonism. The International Journal of Biochemistry & Cell Biology. 83. 39–46. 10 indexed citations
4.
Soloviev, Mikhail, et al.. (2013). Elevated Transcription of the Gene QSOX1 Encoding Quiescin Q6 Sulfhydryl Oxidase 1 in Breast Cancer. PLoS ONE. 8(2). e57327–e57327. 28 indexed citations
5.
Alfano, I., Parvez Vora, Rosemary S. Mummery, Barbara Mulloy, & Christopher C. Rider. (2007). The major determinant of the heparin binding of glial cell-line-derived neurotrophic factor is near the N-terminus and is dispensable for receptor binding. Biochemical Journal. 404(1). 131–140. 31 indexed citations
6.
Mummery, Rosemary S. & Christopher C. Rider. (2004). Characterization of the Heparin-Binding Properties of IL-6. The Journal of Immunology. 173(7). 4755–4755. 9 indexed citations
7.
Gibbs, Roslyn V., et al.. (2003). A role for chondroitin sulphate B in the activity of interleukin 12 in stimulating γ-interferon secretion. Immunology Letters. 85(1). 53–58. 12 indexed citations
8.
Rider, Christopher C.. (2003). Analysis of Glycosaminoglycans and Proteoglycans. Humana Press eBooks. 76. 131–144. 6 indexed citations
9.
Mummery, Rosemary S. & Christopher C. Rider. (2000). Characterization of the Heparin-Binding Properties of IL-6. The Journal of Immunology. 165(10). 5671–5679. 141 indexed citations
10.
Griffin, Philip, et al.. (1999). Cell-surface heparan sulfate facilitates human immunodeficiency virus Type 1 entry into some cell lines but not primary lymphocytes. Virus Research. 60(2). 159–169. 39 indexed citations
11.
Harrop, Hilary A. & Christopher C. Rider. (1998). Heparin and its derivatives bind to HIV-1 recombinant envelope glycoproteins, rather than to recombinant HIV-1 receptor, CD4. Glycobiology. 8(2). 131–137. 59 indexed citations
12.
Vannucci, Susan J., Rosemary S. Mummery, Richard Hawkes, Christopher C. Rider, & Philip Beesley. (1998). Hypoxia—Ischemia Induces a Rapid Elevation of Ubiquitin Conjugate Levels and Ubiquitin Immunoreactivity in the Immature Rat Brain. Journal of Cerebral Blood Flow & Metabolism. 18(4). 376–385. 27 indexed citations
13.
Beesley, Philip, et al.. (1997). JSJ-1, An Anti-Spermidine Monoclonal Antibody With Potential Clinical Applications. Hybridoma. 16(6). 541–543. 1 indexed citations
14.
Coombe, Deirdre R., et al.. (1995). Low Anticoagulant Heparin Retains Anti-HIV Type 1 Activity in Vitro. AIDS Research and Human Retroviruses. 11(11). 1393–1396. 6 indexed citations
15.
Rider, Christopher C., et al.. (1994). Multiple ubiquitin conjugates are present in rat brain synaptic membranes and postsynaptic densities. Neuroscience Letters. 168(1-2). 238–242. 30 indexed citations
16.
Garthwaite, Ian, Anthony D. Stead, & Christopher C. Rider. (1993). Assay of the polyamine spermine by a monoclonal antibody-based ELISA. Journal of Immunological Methods. 162(2). 175–178. 24 indexed citations
17.
Ramsden, Lawrence & Christopher C. Rider. (1992). Selective and differential binding of interleukin (IL)‐1α, IL‐1β, IL‐2 and IL‐6 to glycosaminoglycans. European Journal of Immunology. 22(11). 3027–3031. 109 indexed citations
18.
Wilson, Anne P. & Christopher C. Rider. (1992). Evidence that leukosialin, CD43, is intensely sulfated in the murine T lymphoma line RDM-4. The Journal of Immunology. 148(6). 1777–1783. 8 indexed citations
19.
Wilson, Anne P. & Christopher C. Rider. (1991). Murine T lymphocytes and T-lymphoma cells produce chondroitin sulphate and heparan sulphate proteoglycans and free heparan sulphate glycosaminoglycan.. PubMed. 72(1). 27–33. 12 indexed citations
20.
Rider, Christopher C. & Gerald W. Hart. (1987). Differential sulphation of chondroitins in murine T and B lymphocytes and lymphoma cells. Molecular Immunology. 24(9). 963–967. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amit Choudhury Breakdown of academic impact, for papers by José S. Ramalho Breakdown of academic impact, for papers by Takeshi Matsui Breakdown of academic impact, for papers by Si‐Tse Jiang Breakdown of academic impact, for papers by Christian Zuber Breakdown of academic impact, for papers by Robert Halenbeck Breakdown of academic impact, for papers by Masahiro Oka Breakdown of academic impact, for papers by Martin L. Biniossek Breakdown of academic impact, for papers by François Dautry Breakdown of academic impact, for papers by François Amalric
Rankless by CCL
2026